MedTrials news feed

Information about Medical Trials from around the web. How to apply, latest and general news about medical trials.
Aug 07
Permalink
» Report Examines Cost-Effectiveness Of Larger Clinical Trials To Prevent Postapproval Adverse Events
“Use of Larger Versus Smaller Drug-Safety Databases Before Regulatory Approval: The Trade-Offs,” Health Affairs: In the Web exclusive, Shelby Reed, an associate professor of medicine at the Duke…
Permalink
» Cardinal Health, Inc. Profit Beats Estimates, Explores Spin-off
Cardinal Health, a global provider of products and services that improve the safety and productivity of health care, today reported an increase in fiscal 2008 revenue of 5 percent to $91 billion and…
Permalink
» Genzyme And Isis Begin Second Phase 3 Trial Of Mipomersen
Genzyme Corp. (Nasdaq: GENZ) and Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) announced that they have begun a phase 3 study of mipomersen in patients with heterozygous familial hypercholesterolemia…
Permalink
» Pooled-Analysis Of 54 Clinical Studies Shows No Increased Risk Of Heart Attack With Abacavir Therapy
GlaxoSmithKline (NYSE: GSK) (GSK) announced that a review of data from over 14,600 patients in 54 clinical studies showed no increased risk of myocardial infarction associated with the anti-HIV…
Permalink
» Tolerx Initiates Dosing Of Otelixizumab, A Novel Type 1 Diabetes Agent, In DEFEND, A Phase 3 Clinical Trial
Tolerx, Inc., a biopharmaceutical company engaged in the discovery and development of novel therapies for immune-mediated diseases, announced the initiation of a pivotal Phase 3 clinical trial that…
Permalink
» SCOLR Pharma, Inc. Submits Abbreviated New Drug Application For A 12-hour CDT-based Pseudoephedrine Formulation
Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that 89 percent of surveyed rheumatologists anticipate prescribing…
Permalink
» Oramed Pharmaceuticals Announces Successful Phase 2A Clinical Trial Of Its Oral Insulin Capsule
Oramed Pharmaceuticals, Inc. (OTCBB: ORMP.OB), a developer of oral delivery systems, announced successful results from the clinical trial of its oral insulin capsule, ORMD 0801. The trial…
Permalink
» Mylan Inc. Posts Loss on Acquisition Items
Mylan Inc. today announced its financial results for the three and six months ended June 30, 2008.
Aug 06
Permalink
» Mylan reports loss despite much higher sales
Mylan Inc.’s 2007 purchase of Merck Generics kicked in during the drug maker’s second quarter, more than doubling revenues, but also dragging results into negative territory, the company said today.
Permalink
» Leukemia Journal Publishes Results From Darinaparsin Study
ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) announced the publication of results from a pre-clinical study of darinaparsin (ZIO-101) in the July 17, 2008 on line advance publication issue of Leukemia, a…